Apollon Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$521K Buy
1,859
+294
+19% +$77.3K 0.01% 998
2026
Q1
$418K Buy
1,565
+208
+15% +$56.3K 0.01% 947
2025
Q4
$340K Buy
1,357
+145
+12% +$38.5K 0.01% 1008
2025
Q3
$348K Buy
1,212
+405
+50% +$109K 0.01% 988
2025
Q2
$212K Sell
807
-260
-24% -$63.3K ﹤0.01% 1151
2025
Q1
$248K Sell
1,067
-18
-2% -$4.37K 0.01% 1024
2024
Q4
$249K Buy
+1,085
New +$249K 0.01% 1013
2020
Q3
– Sell
-3
Closed – – 452
2020
Q2
$0 Buy
+3
New +$415 ﹤0.01% 750

Other funds holding LH

Apollon Wealth Management's LH Position: Q2 2026 in Review

Apollon Wealth Management increased its Labcorp (LH) stake by 19% in Q2 2026, buying an estimated $77.3K and bringing the position to 1,859 shares worth $521K. The position accounts for 0.01% of the portfolio, ranked #998.

Apollon Wealth Management first reported a position in LH in Q2 2020 and has held it in 8 quarters since. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Apollon Wealth Management held 1,859 shares of Labcorp worth $521K as of Q2 2026.
  • Apollon Wealth Management bought 294 Labcorp shares in Q2 2026, an estimated $77.3K.
  • Labcorp made up 0.01% of Apollon Wealth Management's portfolio in Q2 2026, its #998 holding.
  • Apollon Wealth Management first reported a position in Labcorp in Q2 2020 and has held it in 8 quarters since.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.